Senior insider sale
Chief Financial Officer at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$2.12M
63.85K shares
What this filing means
ZANTE GREG plans to sell 63.85K shares of VIKING THERAPEUTICS, INC. valued at approximately $2.12M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/5/2026ACC: 0001950047-26-000105
Officer· Chief Financial Officer
Since Jan 2021
63.85K
Shares to sell
$2.12M
Approx. market value
57.66K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Restricted stock vesting under a registered plan
Cash
1/3/2026
39.26KPerformance Stock Units
Cash
1/2/2026
18.18KPerformance Stock Units
Cash
1/2/2026
221.00Total acquired57.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2026 | Restricted stock vesting under a registered plan Cash | 39.26K | — |
1/2/2026 | Performance Stock Units Cash | 18.18K | — |
1/2/2026 | Performance Stock Units Cash | 221.00 | — |
| Total | 57.66K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.18K
Market value
$216.5K
10/28/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
57.66K
Market value
$1.90M
1/5/2026
Total
Units
63.85K
Value
$2.12M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/28/2025 | 6.18K | $216.5K | — | Completed |
| Planned — Approximate Date | ||||
1/5/2026 | 57.66K | $1.90M | NASDAQ | Planned |
| Total | 63.85K | $2.12M | ||